Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Murrell

Showing results (41-50 of 490) with videos related to

Pageof 49
Sort By:
Expert Opinion on Pharmacotherapy|August 19, 2024
The potential of Bruton's tyrosine kinase (BTK) inhibitors in the pharmacotherapeutic management of immune and dermatological diseaseHenry Tseng, Dédée F Murrell
Dermatologic Clinics|May 25, 2011
Objective scoring systems for disease activity in autoimmune bullous diseaseDeshan F Sebaratnam, Dédée F Murrell
International Journal of Women'S Dermatology|October 8, 2021
Embracing diversity in dermatology: Creation of a culture of inclusion in dermatologic publishingJenny E Murase, Dedee F Murrell
Dermatologic Clinics|May 8, 2010
Fibroblast-based cell therapy strategy for recessive dystrophic epidermolysis bullosaW F Yan, Dédée F Murrell
Dermatology Reports|November 12, 2014
Seasonal onychomadesis in an elderly gentlemanSupriya S Venugopal, Dedee F Murrell
JAMA Dermatology|January 10, 2019
Diagnostic Criteria and Phenotypes of Pemphigoid and the Association With GliptinsAsli Bilgic Temel, Dedee F Murrell
JAMA Dermatology|April 5, 2013
Complete resolution of chronic multiple verruca vulgaris treated with quadrivalent human papillomavirus vaccineBenjamin S Daniel, Dedee F Murrell
International Journal of Women'S Dermatology|November 16, 2020
The role of women as past and present advocates for vaccinations: Relevance in the COVID-19 settingBenjamin S Daniel, Dedee F Murrell
The British Journal of Dermatology|March 17, 2017
Increasing prevalence but not incidence of psoriasis in the U.KA E Cust, D F Murrell
Archives of Dermatology|January 23, 2008
Treatment of pemphigus: the need for more evidenceLinda K Martin, Dedee F Murrell
Pageof 49

Showing results (41-50 of 490) with videos related to

Sort By:
Pageof 49
Expert Opinion on Pharmacotherapy|August 19, 2024
The potential of Bruton's tyrosine kinase (BTK) inhibitors in the pharmacotherapeutic management of immune and dermatological diseaseHenry Tseng, Dédée F Murrell
Dermatologic Clinics|May 25, 2011
Objective scoring systems for disease activity in autoimmune bullous diseaseDeshan F Sebaratnam, Dédée F Murrell
International Journal of Women'S Dermatology|October 8, 2021
Embracing diversity in dermatology: Creation of a culture of inclusion in dermatologic publishingJenny E Murase, Dedee F Murrell
Dermatologic Clinics|May 8, 2010
Fibroblast-based cell therapy strategy for recessive dystrophic epidermolysis bullosaW F Yan, Dédée F Murrell
Dermatology Reports|November 12, 2014
Seasonal onychomadesis in an elderly gentlemanSupriya S Venugopal, Dedee F Murrell
JAMA Dermatology|January 10, 2019
Diagnostic Criteria and Phenotypes of Pemphigoid and the Association With GliptinsAsli Bilgic Temel, Dedee F Murrell
JAMA Dermatology|April 5, 2013
Complete resolution of chronic multiple verruca vulgaris treated with quadrivalent human papillomavirus vaccineBenjamin S Daniel, Dedee F Murrell
International Journal of Women'S Dermatology|November 16, 2020
The role of women as past and present advocates for vaccinations: Relevance in the COVID-19 settingBenjamin S Daniel, Dedee F Murrell
The British Journal of Dermatology|March 17, 2017
Increasing prevalence but not incidence of psoriasis in the U.KA E Cust, D F Murrell
Archives of Dermatology|January 23, 2008
Treatment of pemphigus: the need for more evidenceLinda K Martin, Dedee F Murrell
Pageof 49